InvestorsHub Logo
Followers 9
Posts 152
Boards Moderated 0
Alias Born 01/28/2014

Re: None

Monday, 03/24/2014 1:56:58 PM

Monday, March 24, 2014 1:56:58 PM

Post# of 29332
Here is another article - this one from an MD at the Boston University School of Medicine Department of Neurology. I am trying to stay away from weed blog articles (not that I have a problem with them), so the science is well founded. Maybe some of these links need to find their way into a Medical side DD sticky. ;)

http://www.medscape.com/viewarticle/781651_2

here is the conclusions excerpt

"Cannabinoids enjoyed considerable prominence in the early medical pharmacopeia, advocated by top physicians of the time, and continue to be used by patients for relief of headache generally without physician recommendation. There is much anecdotal support and experimental evidence for this use but no good clinical trials for headache. The actions of cannabinoids, including the analgesic activity on the trigeminal nucleus caudalis, presynaptic inhibition of glutamate release, an anti-inflammatory effect, anti-emetic effect, and vasoconstrictive effect appear to make cannabinoids a good migraine treatment, albeit with health concerns in connection with smoking and overuse. Progressive state legislature support for medical marijuana is making this option somewhat easier for health care professionals, but remains federally prohibited. Ergotamine-related hallucinogen use has become popular among some cluster headache sufferers, again with anecdotal but compelling success in relieving headache along with a credible biological rationale. Deficits in medical therapy in particular have led to self-treatment with cannabinoids and hallucinogens to become increasingly popular, notwithstanding the habit forming potential in certain individuals. The future may bring therapeutic options based on these treatments, with new research and clinical study."

Bacon. It's Everywhere You Want To Be.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.